ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neuromodulation and Neurostimulation Pain Management Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-0L17453
Home | Market Reports | Health| Health Conditions| Pain Management
Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024
BUY CHAPTERS

Global Neuromodulation and Neurostimulation Pain Management Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0L17453
Report
November 2025
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medtronic Inc
Boston Scientific Corporation
Pfizer Inc. (Hospira Inc.)
Stryker Corporation
Abbott Laboratories
B Braun Melsungen AG
Baxter International Inc
Johnson & Johnson (Codman And Shurtleff, Inc.)
Kimberly-Clark Corporation (Baylis Medical)
Colfax Corporation (Djo Global Llc)
Johnson & Johnson (Codman And Shurtleff, Inc.)

Neuromodulation and Neurostimulation Pain Management Devices Market Size

The global Neuromodulation and Neurostimulation Pain Management Devices market is projected to grow from US$ 2265 million in 2024 to US$ 3484 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications.

Neuromodulation and Neurostimulation Pain Management Devices Market

Neuromodulation and Neurostimulation Pain Management Devices Market

Pain management is a branch of medical science, which eases the suffering of patients who suffer from chronic pain. Acute pain has sudden onset of action, whereas chronic pain persists for a longer duration, which leads to need for its management. Neuromodulation and Neurostimulation Pain Management Devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are various types of pain management devices available in the market. The growth of the global pain management devices market is driven by increase in geriatric population, rise in prevalence of chronic pain, surge in geriatric population, surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and launch of innovative products. In addition, increase in demand for pain management devices among the developing countries and rise in adoption of pain management devices for management of chronic pain are other factors that contribute toward the growth of the market. Furthermore, untapped potential offered by developing economies present lucrative opportunities for market expansion during the forecast period. However, hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption, which hampers the growth of the market. Moreover, these devices are usually used as second line of treatment in patients with chronic pain who become resistant to drug therapy, which limits the growth of the global pain management devices market.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Neuromodulation and Neurostimulation Pain Management Devices market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Neuromodulation and Neurostimulation Pain Management Devices Market Report

Report Metric Details
Report Name Neuromodulation and Neurostimulation Pain Management Devices Market
Accounted market size in 2024 US$ 2265 million
Forecasted market size in 2031 US$ 3484 million
CAGR 6.4%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Spinal Cord Stimulators
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Segment by Application
  • Neuropathic Pain
  • Cancer Pain
  • Facial & Migraine Pain
  • Musculoskeletal Pain
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Neuromodulation and Neurostimulation Pain Management Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Neuromodulation and Neurostimulation Pain Management Devices Market growing?

Ans: The Neuromodulation and Neurostimulation Pain Management Devices Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Neuromodulation and Neurostimulation Pain Management Devices Market size in 2031?

Ans: The Neuromodulation and Neurostimulation Pain Management Devices Market size in 2031 will be US$ 3484 million.

Who are the main players in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The main players in the Neuromodulation and Neurostimulation Pain Management Devices Market are Medtronic Plc, Boston Scientific Corporation, Pfizer Inc. (Hospira Inc.), Johnson & Johnson (Codman And Shurtleff, Inc.), Stryker Corporation, Kimberly-Clark Corporation (Baylis Medical), Colfax Corporation (Djo Global Llc), Abbott Laboratories, B Braun Melsungen Ag, Baxter International Inc.

What are the Application segmentation covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The Applications covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report are Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Others

What are the Type segmentation covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report?

Ans: The Types covered in the Neuromodulation and Neurostimulation Pain Management Devices Market report are Spinal Cord Stimulators, Transcutaneous Electrical Nerve Stimulation (TENS) Devices

1 Study Coverage
1.1 Introduction to Neuromodulation and Neurostimulation Pain Management Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Spinal Cord Stimulators
1.2.3 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
1.3 Market Segmentation by Application
1.3.1 Global Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Neuropathic Pain
1.3.3 Cancer Pain
1.3.4 Facial & Migraine Pain
1.3.5 Musculoskeletal Pain
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Neuromodulation and Neurostimulation Pain Management Devices Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Neuromodulation and Neurostimulation Pain Management Devices Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Spinal Cord Stimulators Market Size by Players
3.3.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices Market Size by Players
3.4 Global Neuromodulation and Neurostimulation Pain Management Devices Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2020-2031)
6.4 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2020-2031)
7.4 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2020-2031)
8.4 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2020-2031)
9.4 Central and South America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Type (2020-2031)
10.4 Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic Plc
11.1.1 Medtronic Plc Corporation Information
11.1.2 Medtronic Plc Business Overview
11.1.3 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.1.4 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue by Product in 2024
11.1.6 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application in 2024
11.1.7 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices Revenue by Geographic Area in 2024
11.1.8 Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
11.1.9 Medtronic Plc Recent Developments
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Corporation Information
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.2.4 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.2.5 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Product in 2024
11.2.6 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application in 2024
11.2.7 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Geographic Area in 2024
11.2.8 Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
11.2.9 Boston Scientific Corporation Recent Developments
11.3 Pfizer Inc. (Hospira Inc.)
11.3.1 Pfizer Inc. (Hospira Inc.) Corporation Information
11.3.2 Pfizer Inc. (Hospira Inc.) Business Overview
11.3.3 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.3.4 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.3.5 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Product in 2024
11.3.6 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application in 2024
11.3.7 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Geographic Area in 2024
11.3.8 Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
11.3.9 Pfizer Inc. (Hospira Inc.) Recent Developments
11.4 Johnson & Johnson (Codman And Shurtleff, Inc.)
11.4.1 Johnson & Johnson (Codman And Shurtleff, Inc.) Corporation Information
11.4.2 Johnson & Johnson (Codman And Shurtleff, Inc.) Business Overview
11.4.3 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.4.4 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.4.5 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Product in 2024
11.4.6 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application in 2024
11.4.7 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices Revenue by Geographic Area in 2024
11.4.8 Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
11.4.9 Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Developments
11.5 Stryker Corporation
11.5.1 Stryker Corporation Corporation Information
11.5.2 Stryker Corporation Business Overview
11.5.3 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.5.4 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.5.5 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Product in 2024
11.5.6 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application in 2024
11.5.7 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices Revenue by Geographic Area in 2024
11.5.8 Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
11.5.9 Stryker Corporation Recent Developments
11.6 Kimberly-Clark Corporation (Baylis Medical)
11.6.1 Kimberly-Clark Corporation (Baylis Medical) Corporation Information
11.6.2 Kimberly-Clark Corporation (Baylis Medical) Business Overview
11.6.3 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.6.4 Kimberly-Clark Corporation (Baylis Medical) Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.6.5 Kimberly-Clark Corporation (Baylis Medical) Recent Developments
11.7 Colfax Corporation (Djo Global Llc)
11.7.1 Colfax Corporation (Djo Global Llc) Corporation Information
11.7.2 Colfax Corporation (Djo Global Llc) Business Overview
11.7.3 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.7.4 Colfax Corporation (Djo Global Llc) Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.7.5 Colfax Corporation (Djo Global Llc) Recent Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Corporation Information
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.8.4 Abbott Laboratories Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Laboratories Recent Developments
11.9 B Braun Melsungen Ag
11.9.1 B Braun Melsungen Ag Corporation Information
11.9.2 B Braun Melsungen Ag Business Overview
11.9.3 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.9.4 B Braun Melsungen Ag Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.9.5 B Braun Melsungen Ag Recent Developments
11.10 Baxter International Inc.
11.10.1 Baxter International Inc. Corporation Information
11.10.2 Baxter International Inc. Business Overview
11.10.3 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Product Features and Attributes
11.10.4 Baxter International Inc. Neuromodulation and Neurostimulation Pain Management Devices Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Neuromodulation and Neurostimulation Pain Management DevicesIndustry Chain Analysis
12.1 Neuromodulation and Neurostimulation Pain Management Devices Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Neuromodulation and Neurostimulation Pain Management Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Neuromodulation and Neurostimulation Pain Management Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Medtronic Inc
Boston Scientific Corporation
Pfizer Inc. (Hospira Inc.)
Stryker Corporation
Abbott Laboratories
B Braun Melsungen AG
Baxter International Inc
Johnson & Johnson (Codman And Shurtleff, Inc.)
Kimberly-Clark Corporation (Baylis Medical)
Colfax Corporation (Djo Global Llc)
Johnson & Johnson (Codman And Shurtleff, Inc.)
List of Tables
 Table 1. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Neuromodulation and Neurostimulation Pain Management Devices by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation and Neurostimulation Pain Management Devices as of 2024)
 Table 11. Global Neuromodulation and Neurostimulation Pain Management Devices Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Neuromodulation and Neurostimulation Pain Management Devices Companies Headquarters
 Table 13. Global Neuromodulation and Neurostimulation Pain Management Devices Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Neuromodulation and Neurostimulation Pain Management Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Neuromodulation and Neurostimulation Pain Management Devices Growth Accelerators and Market Barriers
 Table 25. North America Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Neuromodulation and Neurostimulation Pain Management Devices Growth Accelerators and Market Barriers
 Table 27. Europe Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Neuromodulation and Neurostimulation Pain Management Devices Investment Opportunities and Key Challenges
 Table 31. Central and South America Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Medtronic Plc Corporation Information
 Table 35. Medtronic Plc Description and Major Businesses
 Table 36. Medtronic Plc Product Features and Attributes
 Table 37. Medtronic Plc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Medtronic Plc Revenue Proportion by Product in 2024
 Table 39. Medtronic Plc Revenue Proportion by Application in 2024
 Table 40. Medtronic Plc Revenue Proportion by Geographic Area in 2024
 Table 41. Medtronic Plc Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
 Table 42. Medtronic Plc Recent Developments
 Table 43. Boston Scientific Corporation Corporation Information
 Table 44. Boston Scientific Corporation Description and Major Businesses
 Table 45. Boston Scientific Corporation Product Features and Attributes
 Table 46. Boston Scientific Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Boston Scientific Corporation Revenue Proportion by Product in 2024
 Table 48. Boston Scientific Corporation Revenue Proportion by Application in 2024
 Table 49. Boston Scientific Corporation Revenue Proportion by Geographic Area in 2024
 Table 50. Boston Scientific Corporation Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
 Table 51. Boston Scientific Corporation Recent Developments
 Table 52. Pfizer Inc. (Hospira Inc.) Corporation Information
 Table 53. Pfizer Inc. (Hospira Inc.) Description and Major Businesses
 Table 54. Pfizer Inc. (Hospira Inc.) Product Features and Attributes
 Table 55. Pfizer Inc. (Hospira Inc.) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Pfizer Inc. (Hospira Inc.) Revenue Proportion by Product in 2024
 Table 57. Pfizer Inc. (Hospira Inc.) Revenue Proportion by Application in 2024
 Table 58. Pfizer Inc. (Hospira Inc.) Revenue Proportion by Geographic Area in 2024
 Table 59. Pfizer Inc. (Hospira Inc.) Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
 Table 60. Pfizer Inc. (Hospira Inc.) Recent Developments
 Table 61. Johnson & Johnson (Codman And Shurtleff, Inc.) Corporation Information
 Table 62. Johnson & Johnson (Codman And Shurtleff, Inc.) Description and Major Businesses
 Table 63. Johnson & Johnson (Codman And Shurtleff, Inc.) Product Features and Attributes
 Table 64. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue Proportion by Product in 2024
 Table 66. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue Proportion by Application in 2024
 Table 67. Johnson & Johnson (Codman And Shurtleff, Inc.) Revenue Proportion by Geographic Area in 2024
 Table 68. Johnson & Johnson (Codman And Shurtleff, Inc.) Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
 Table 69. Johnson & Johnson (Codman And Shurtleff, Inc.) Recent Developments
 Table 70. Stryker Corporation Corporation Information
 Table 71. Stryker Corporation Description and Major Businesses
 Table 72. Stryker Corporation Product Features and Attributes
 Table 73. Stryker Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Stryker Corporation Revenue Proportion by Product in 2024
 Table 75. Stryker Corporation Revenue Proportion by Application in 2024
 Table 76. Stryker Corporation Revenue Proportion by Geographic Area in 2024
 Table 77. Stryker Corporation Neuromodulation and Neurostimulation Pain Management Devices SWOT Analysis
 Table 78. Stryker Corporation Recent Developments
 Table 79. Kimberly-Clark Corporation (Baylis Medical) Corporation Information
 Table 80. Kimberly-Clark Corporation (Baylis Medical) Description and Major Businesses
 Table 81. Kimberly-Clark Corporation (Baylis Medical) Product Features and Attributes
 Table 82. Kimberly-Clark Corporation (Baylis Medical) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Kimberly-Clark Corporation (Baylis Medical) Recent Developments
 Table 84. Colfax Corporation (Djo Global Llc) Corporation Information
 Table 85. Colfax Corporation (Djo Global Llc) Description and Major Businesses
 Table 86. Colfax Corporation (Djo Global Llc) Product Features and Attributes
 Table 87. Colfax Corporation (Djo Global Llc) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Colfax Corporation (Djo Global Llc) Recent Developments
 Table 89. Abbott Laboratories Corporation Information
 Table 90. Abbott Laboratories Description and Major Businesses
 Table 91. Abbott Laboratories Product Features and Attributes
 Table 92. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Abbott Laboratories Recent Developments
 Table 94. B Braun Melsungen Ag Corporation Information
 Table 95. B Braun Melsungen Ag Description and Major Businesses
 Table 96. B Braun Melsungen Ag Product Features and Attributes
 Table 97. B Braun Melsungen Ag Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. B Braun Melsungen Ag Recent Developments
 Table 99. Baxter International Inc. Corporation Information
 Table 100. Baxter International Inc. Description and Major Businesses
 Table 101. Baxter International Inc. Product Features and Attributes
 Table 102. Baxter International Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Baxter International Inc. Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Neuromodulation and Neurostimulation Pain Management Devices Product Picture
 Figure 2. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Spinal Cord Stimulators Product Picture
 Figure 4. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Product Picture
 Figure 5. Global Neuromodulation and Neurostimulation Pain Management Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Neuropathic Pain
 Figure 7. Cancer Pain
 Figure 8. Facial & Migraine Pain
 Figure 9. Musculoskeletal Pain
 Figure 10. Others
 Figure 11. Neuromodulation and Neurostimulation Pain Management Devices Report Years Considered
 Figure 12. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Region (2020-2031)
 Figure 16. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Spinal Cord Stimulators Revenue Market Share by Player in 2024
 Figure 19. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Revenue Market Share by Player in 2024
 Figure 20. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Type (2020-2031)
 Figure 21. Global Neuromodulation and Neurostimulation Pain Management Devices Revenue Market Share by Application (2020-2031)
 Figure 22. North America Neuromodulation and Neurostimulation Pain Management Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) in 2024
 Figure 24. North America Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Neuromodulation and Neurostimulation Pain Management Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) in 2024
 Figure 31. Europe Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 34. France Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 46. India Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Neuromodulation and Neurostimulation Pain Management Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) in 2024
 Figure 54. Central and South America Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) in 2024
 Figure 60. South America Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Neuromodulation and Neurostimulation Pain Management Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Neuromodulation and Neurostimulation Pain Management Devices Revenue (2020-2025) & (US$ Million)
 Figure 66. Neuromodulation and Neurostimulation Pain Management Devices Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Implantable Neuromodulation Device Market Research Report 2025
Global Implantable Neuromodulation System Market Research Report 2024
Implantable Neurostimulation Devices Market
Global Implantable Neurostimulation System Market Research Report 2024
Global Implantable Neurostimulators Market Research Report 2024
Internal Neuromodulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Neuromodulation Device Market Research Report 2024
Low Frequency Sine Wave Neurostimulation Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuropathic Pain Management Market Insights Forecast to 2030
Global Pain Management and Surgical Devices Market Insights Forecast to 2030
Global Home Neuromodulation Device Market Research Report 2024
Global Neurostimulation and Neuromodulation Device Market Research Report 2024
Global Neuromodulation Sensor Market Research Report 2025
Global Spinal Cord Stimulation System Market Research Report 2024
Global Implantable Nerve Stimulation Market Research Report 2024
Global Neurostimulator Medical Device Market Research Report 2024
Global Pain Management Drugs Devices Market Research Report 2025
Global Virtual Reality Therapy for Pain Management Market Research Report 2024
Global Ocular Neuromodulation Device Market Research Report 2025
Global Pain Monitoring Device Market Research Report 2024

RELATED REPORTS

Global Muscle Pain Relief Patches Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6F17019
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Neuromodulation and Neurostimulation Pain Management Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-0L17453
Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Global Pain Relief Gel Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-35S16884
Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Global Locoplex Plexus and Peripheral Nerve Block Needle Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-25Q17042
Tue Nov 04 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions